Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
freem
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Openai/693ba2e3-b928-8004-920f-e506d7f76c92
(section)
Add languages
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Special pages
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==== 16. 病人衛教與追蹤（Patient Counseling / Monitoring） ==== : 以下為「仿單風險導向」之教科書式彙整。 * 胃腸道反應與脫水風險：告知噁心、嘔吐、腹瀉等常見；若嚴重或持續需評估脫水與腎功能惡化風險並追蹤腎功能（尤其腎功能不全者）。【TFDA｜Warnings】Mounjaro 衛部藥輸字第028468號114.05.21 * 胰臟炎/膽囊疾病警訊教育：出現持續性劇烈腹痛（或右上腹痛、發燒、黃疸）時需就醫評估（概念性）。【TFDA｜Warnings】Wegovy 衛部菌疫輸字第001224號114.03.04 * 低血糖風險（合併用藥）：若與胰島素或磺醯脲類併用，需警覺低血糖與可能的合併用藥劑量調整議題（概念性）。【TFDA｜Warnings】Mounjaro 衛部藥輸字第028468號114.05.21 * 甲狀腺腫瘤症狀教育（具警告者）：頸部腫塊、吞嚥困難、呼吸困難、持續聲音嘶啞等；並提醒禁忌族群（MTC/MEN2）。【TFDA｜Boxed Warning】Mounjaro 衛部藥輸字第028468號114.05.21 * 手術/麻醉前揭露用藥史：因延遲胃排空，麻醉/深度鎮靜下可能發生肺部異物吸入風險；需於麻醉評估時主動揭露（概念性）。【TFDA｜Warnings】Trulicity 衛部菌疫輸字第000978號114.05.… * 體重管理藥物之精神症狀追蹤：Wegovy/Saxenda/Mounjaro 仿單載明需監測憂鬱、情緒變化與自殺意念。【TFDA｜Warnings】Mounjaro 衛部藥輸字第028468號114.05.21
Summary:
Please note that all contributions to freem are considered to be released under the Creative Commons Attribution-ShareAlike 4.0 (see
Freem:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
